181 related articles for article (PubMed ID: 3146942)
1. [Intravesical mitomycin for superficial tumors of the bladder: difficulties of cystoscopic monitoring].
Fourcade RO; Giuliano F
Ann Urol (Paris); 1988; 22(6):404-6. PubMed ID: 3146942
[TBL] [Abstract][Full Text] [Related]
2. [Can topical chemoprevention modify the rate of recurrence and progression of superficial bladder cancer?].
Egghart G; Steegmüller O; Wenderoth U; Hautmann R
Urologe A; 1988 May; 27(3):147-51. PubMed ID: 3136576
[TBL] [Abstract][Full Text] [Related]
3. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
4. Mitomycin-C and BCG in intravesical chemotherapy and immunotherapy of superficial bladder cancer. Finnbladder Research Group.
Rintala E; Jauhiainen K; Alfthan O
Prog Clin Biol Res; 1989; 310():271-4. PubMed ID: 2505270
[No Abstract] [Full Text] [Related]
5. Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy.
van der Meijden AP; DeBruyne FM
Urology; 1988 Mar; 31(3 Suppl):26-9. PubMed ID: 3126592
[TBL] [Abstract][Full Text] [Related]
6. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
[TBL] [Abstract][Full Text] [Related]
7. [Mitomycin C in the topical treatment of superficial neoplasms of the bladder].
Milani C; Bassi PF; Meneghini A; Giunta A; Tejerizo JC; dal Bianco M; Zattoni F; Garbeglio A
Arch Esp Urol; 1989 Oct; 42(8):761-7. PubMed ID: 2515812
[TBL] [Abstract][Full Text] [Related]
8. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
Kurth KH; Bouffioux C; Sylvester R; de Pauw M
Prog Clin Biol Res; 1988; 269():525-37. PubMed ID: 3134663
[No Abstract] [Full Text] [Related]
9. Intravesical mitomycin C instillation as a prophylactic treatment of superficial bladder tumor.
Kim HH; Lee C
J Urol; 1989 Jun; 141(6):1337-9; discussion 1339-40. PubMed ID: 2498532
[TBL] [Abstract][Full Text] [Related]
10. [Combination chemotherapy of mitomycin C and cytosine arabinoside in the intravesical treatment for superficial bladder tumors: report 2. Evaluation of prophylactic intravesical infusion therapy].
Ikeuchi T; Onodera Y; Kai Y
Gan To Kagaku Ryoho; 1984 Apr; 11(4):858-63. PubMed ID: 6426397
[TBL] [Abstract][Full Text] [Related]
11. Intravesical mitomycin C and superficial bladder tumors.
Biserte J; Rigot JM; Mauroy B; Mazeman E
Prog Clin Biol Res; 1989; 303():411-5. PubMed ID: 2506555
[No Abstract] [Full Text] [Related]
12. [Combination chemotherapy of mitomycin C and cytosine arabinoside in superficial bladder tumors. 1. Evaluation of intravesical infusion therapy].
Ikeuchi T; Onodera Y; Kai Y
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2145-51. PubMed ID: 6414383
[TBL] [Abstract][Full Text] [Related]
13. Re: Recurrence of superficial bladder carcinoma after intravesical instillation of Mitomycin-C.
Parmar MK
Br J Urol; 1989 Dec; 64(6):659. PubMed ID: 2516758
[No Abstract] [Full Text] [Related]
14. Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).
Tolley DA; Hargreave TB; Smith PH; Williams JL; Grigor KM; Parmar MK; Freedman LS; Uscinska BM
Br Med J (Clin Res Ed); 1988 Jun; 296(6639):1759-61. PubMed ID: 3136828
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of intravesical mitomycin C in the treatment of superficial transitional cell carcinoma of the urinary bladder.
Pavlotsky A; Eidelman A; Barak F; Alon H; Horn Y
J Surg Oncol; 1989 May; 41(1):9-11. PubMed ID: 2497274
[TBL] [Abstract][Full Text] [Related]
16. Use of mitomycin as prophylaxis following endoscopic resection of superficial bladder cancer.
Huland H; Otto U
Urology; 1985 Oct; 26(4 Suppl):32-5. PubMed ID: 4049627
[TBL] [Abstract][Full Text] [Related]
17. [Stage P-1 primary neoplasia of the bladder. Critical evaluation of results obtained with the use of adriamycin and mitomycin C in the prevention of recurrences].
Liberti M; Tenaglia R; De Berardinis E; Gentile V
Minerva Med; 1984 Feb; 75(8):391-4. PubMed ID: 6424059
[TBL] [Abstract][Full Text] [Related]
18. [Cytoscopic follow-up of initial G3T1 bladder tumors treated with BCG].
Pieras Ayala E; Palou J; Rodríguez-Villamil L; Millán Rodríguez F; Salvador Bayarri J; Vicente Rodríguez J
Arch Esp Urol; 2001 Apr; 54(3):211-7. PubMed ID: 11432035
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup.
Solsona E; Iborra I; Ricós JV; Monrós JL; Casanova J; Dumont R
J Urol; 1999 Apr; 161(4):1120-3. PubMed ID: 10081851
[TBL] [Abstract][Full Text] [Related]
20. Study of intravesical mitomycin C in patients with multiple prior occurrences of superficial bladder cancer.
Schwarzman MI; Johanson KE; Surya B; Brown J
Urology; 1988 Oct; 32(4):335-8. PubMed ID: 3140465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
